Capnia, Inc. (NASDAQ:SLNO) was upgraded by ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Friday.
Separately, Maxim Group set a $25.00 price objective on Capnia and gave the stock a “buy” rating in a research note on Monday, August 14th.
Shares of Capnia (SLNO) opened at 2.44 on Friday. The company’s market cap is $116.93 million. The stock’s 50 day moving average price is $0.59 and its 200-day moving average price is $0.59. Capnia has a 12 month low of $0.29 and a 12 month high of $3.00.
Capnia (NASDAQ:SLNO) last released its quarterly earnings data on Friday, August 11th. The company reported ($0.30) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.40) by $0.10. Capnia had a negative return on equity of 69.67% and a negative net margin of 1,389.76%. Equities research analysts expect that Capnia will post ($0.27) earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Capnia, Inc. (SLNO) Rating Increased to Sell at ValuEngine” was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://transcriptdaily.com/2017/10/08/capnia-inc-slno-rating-increased-to-sell-at-valuengine.html.
Capnia Company Profile
Soleno Therapeutics, Inc, formerly Capnia, Inc, is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief.
Receive News & Ratings for Capnia Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capnia Inc. and related companies with MarketBeat.com's FREE daily email newsletter.